AVIR Atea Pharmaceuticals, Inc. - common stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 12, 2026
$5,13
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,8152-Wochen-Tief
$6,4552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$411M
P/E
-2.6
EPS
$-1.94
Ihre Abzeichen
52W-Spanne
$3–$6
Analystenbewertung
BUY
Kursziel
$9
P/E
-2.6
ROE
-49.5%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
AVIR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.13
Marktkapitalisierung (MRQ)
$411M
P/E
-2.6
EPS
$-1.94
ROE
-49.5%
52W-Spanne
$3–$6
AVIR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2020-12-31 → 2021-12-31
EPS$-1.942019-12-31 → 2025-12-31
Freier Cashflow·2020-12-31 → 2022-12-31
Nettogewinnmarge·2020-12-31 → 2021-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | AVIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -2.65-Jahres-Durchschnitt ≈-0.5 | ≈-0.5 | · | · | |
| K/B (MRQ) | 2.05-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 2.7 | Unterbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -3.05-Jahres-Durchschnitt ≈-3.8 | ≈-3.8 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.55-Jahres-Durchschnitt ≈0.8 | ≈0.8 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | AVIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -40.6%5-Jahres-Durchschnitt ≈-19.0% | ≈-19.0% | -24.5% | Schwach | |
| ROE | -49.5%5-Jahres-Durchschnitt ≈-22.0% | ≈-22.0% | -27.7% | Schwach | |
| ROIC | -63.2%5-Jahres-Durchschnitt ≈-28.0% | ≈-28.0% | -26.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | AVIR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 8.15-Jahres-Durchschnitt ≈20.1 | ≈20.1 | 7.9 | Im Einklang | |
| Quick Ratio | 2.45-Jahres-Durchschnitt ≈6.8 | ≈6.8 | 2.7 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
1.7%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.41 | $-0.57 | 28.2% |
| 31. März 2026 | Mai 13, 2026 | $-0.57 | $-0.60 | 5.3% |
| 31. Dezember 2025 | $-0.57 | $-0.54 | -5.4% | |
| 30. September 2025 | $-0.53 | $-0.45 | -18.1% | |
| 30. Juni 2025 | $-0.44 | $-0.42 | -3.9% | |
| 31. März 2025 | $-0.40 | $-0.42 | 4.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $351M | $49M | |
| R&D Expense | $148M | $144M | $114M | $82M | $167M | $38M | |
| SG&A Expense | $33M | $49M | $50M | $49M | $46M | $22M | |
| Operating Expenses | $181M | $193M | $164M | $131M | $213M | $60M | |
| Operating Income | $-181M | $-193M | $-164M | $-131M | $138M | $-11M | |
| Pretax Income | $-165M | $-167M | $-135M | $-119M | $139M | $-11M | |
| Income Tax | $-6M | $925.0K | $1M | $-4M | $17M | · | |
| Net Income | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| EPS (Basic) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.46 | $-0.51 | |
| EPS (Diluted) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 | |
| Shares (Basic) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 82,820,037 | 21,592,441 | |
| Shares (Diluted) | 81,495,352 | 84,264,715 | 83,389,750 | 83,245,385 | 88,249,243 | 21,592,441 | |
| EBITDA | $-181M | $-193M | $-164M | $-131M | $138M | $-11M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $96M | $65M | $144M | $188M | $764M | $850M | |
| Prepaid Expense | $9M | $8M | $12M | $14M | $8M | $8M | |
| Current Assets | $311M | $462M | $590M | $661M | $772M | $863M | |
| PP&E (Net) | $457.0K | $873.0K | $1M | $2M | $23.0K | $48.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $184.0K | $180.0K | |
| Accum. Depreciation | $2M | $1M | $689.0K | $273.0K | $161.0K | $132.0K | |
| Other Non-current Assets | $3M | $197.0K | $1M | $1M | $466.0K | $107.0K | |
| Total Assets | $315M | $465M | $595M | $667M | $773M | $864M | |
| Accounts Payable | $13M | $4M | $4M | $3M | $5M | $60.0K | |
| Current Liabilities | $40M | $19M | $32M | $18M | $57M | $316M | |
| Capital Leases | $0 | $842.0K | $2M | $2M | · | · | |
| Other Non-current Liabilities | · | · | · | · | $6M | $36.0K | |
| Total Liabilities | $40M | $26M | $40M | $26M | $63M | $316M | |
| Common Stock | $78.0K | $84.0K | $83.0K | $83.0K | $83.0K | $82.0K | |
| Paid-in Capital | $798M | $803M | $751M | $701M | $654M | $613M | |
| Retained Earnings | $-523M | $-364M | $-196M | $-60M | $56M | $-65M | |
| AOCI | $174.0K | $233.0K | $207.0K | $-684.0K | · | · | |
| Stockholders' Equity | $275M | $439M | $555M | $641M | $710M | $548M | |
| Liabilities + Equity | $315M | $465M | $595M | $667M | $773M | $864M | |
| Shares Outstanding | 78,126,796 | 84,463,059 | 83,435,513 | 83,287,639 | 83,102,730 | 82,436,937 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $416.0K | $416.0K | $416.0K | $260.0K | $29.0K | $19.0K | |
| Stock-based Comp | $21M | $52M | $49M | $47M | $40M | $7M | |
| Deferred Tax | $-6M | $0 | · | · | · | $0 | |
| Operating Cash Flow | $-132M | $-135M | $-85M | $-121M | $-87M | $297M | |
| CapEx | · | · | · | $2M | $4.0K | $26.0K | |
| Investing Cash Flow | $189M | $56M | $40M | $-455M | $-4.0K | $-26.0K | |
| Stock Issued | · | · | · | · | $1M | $27.0K | |
| Stock Repurchased | $26M | $0 | · | · | · | · | |
| Net Stock Activity | $-26M | · | · | · | $1M | $27.0K | |
| Financing Cash Flow | $-26M | $267.0K | $257.0K | $370.0K | $1M | $532M | |
| Net Change in Cash | $31M | $-79M | $-45M | $-576M | $-86M | $828M | |
| Free Cash Flow | · | · | · | $-123M | $-87M | $297M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | 39.4% | -22.7% | |
| Net Margin | · | · | · | · | 34.5% | -22.5% | |
| Pretax Margin | · | · | · | · | 39.4% | · | |
| EBITDA Margin | · | · | · | · | 39.4% | -22.7% | |
| ROA | -40.6% | -31.8% | -21.6% | -16.1% | 14.8% | -2.5% | |
| ROE | -49.5% | -37.5% | -23.9% | -17.8% | 18.8% | -4.7% | |
| ROIC | -63.2% | -44.2% | -29.8% | -19.8% | 17.0% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 | 2.7 | |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 | 2.7 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.4 | 0.1 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.53 | $5.20 | $6.65 | $7.69 | $8.54 | $6.65 | |
| Revenue / Share | · | · | · | · | $3.98 | · | |
| Cash Flow / Share | $-1.62 | $-1.61 | $-1.02 | $-1.45 | $-0.99 | · | |
| Cash / Share | $1.23 | $0.77 | $1.72 | $2.26 | $9.20 | $10.31 | |
| EPS (TTM) | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 | $-0.51 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | 622.5% | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $351M | $49M | |
| Net Income TTM | $-158M | $-168M | $-136M | $-116M | $121M | $-11M | |
| Market Cap | $279M | $283M | $254M | $401M | $743M | $3.44B | |
| P/E | -1.8 | -1.7 | -1.9 | -3.5 | 6.5 | -81.9 | |
| P/S | · | · | · | · | 2.1 | 70.8 | |
| P/B | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Tangible Book | 1.0 | 0.6 | 0.5 | 0.6 | 1.0 | 6.3 | |
| P / Cash Flow | -2.1 | -2.1 | -3.0 | -3.3 | -8.5 | 11.6 | |
| P / FCF | · | · | · | -3.3 | -8.5 | 11.6 | |
| Earnings Yield | -54.3% | -59.7% | -53.4% | -28.9% | 15.3% | -1.2% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $41M | $48M | $38M | $32M | $30M | $26M | $26M | $35M | $58M | $35M | $28M | $22M | $29M | $28M | $5M | |
| SG&A Expense | $7M | $7M | $7M | $7M | $9M | $9M | $13M | $11M | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $11M | |
| Operating Expenses | $35M | $48M | $55M | $46M | $41M | $39M | $39M | $37M | $47M | $70M | $47M | $41M | $35M | $42M | $40M | $16M | |
| Operating Income | $-35M | $-48M | $-55M | $-46M | $-41M | $-39M | $-39M | $-37M | $-47M | $-70M | $-47M | $-41M | $-35M | $-42M | $-40M | $-16M | |
| Pretax Income | $-33M | $-45M | $-52M | $-42M | $-37M | $-34M | $-33M | $-31M | $-40M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-12M | |
| Income Tax | $24.0K | $50.0K | $-7M | $196.0K | $207.0K | $203.0K | $225.0K | $226.0K | $243.0K | $231.0K | $349.0K | $221.0K | $251.0K | $197.0K | $123.0K | $-4M | |
| Net Income | $-33M | $-45M | $-45M | $-42M | $-37M | $-34M | $-34M | $-31M | $-41M | $-63M | $-39M | $-33M | $-28M | $-35M | $-34M | $-8M | |
| EPS (Basic) | $-0.41 | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | |
| EPS (Diluted) | $-0.41 | $-0.57 | $-0.57 | $-0.53 | $-0.44 | $-0.40 | $-0.40 | $-0.37 | $-0.48 | $-0.75 | $-0.46 | $-0.40 | $-0.34 | $-0.43 | $-0.40 | $-0.10 | |
| Shares (Basic) | 80,050,518 | 79,198,204 | · | 79,052,154 | 83,747,335 | 85,159,254 | · | 84,422,000 | 84,253,700 | 83,916,193 | · | 83,399,769 | 83,399,377 | 83,332,397 | · | 83,258,537 | |
| Shares (Diluted) | 80,050,518 | 79,198,204 | · | 79,052,154 | 83,747,335 | 85,159,254 | · | 84,422,000 | 84,253,700 | 83,916,193 | · | 83,399,769 | 83,399,377 | 83,332,397 | · | 83,258,537 | |
| EBITDA | $-35M | $-48M | · | $-46M | $-41M | $-39M | · | $-37M | $-47M | $-70M | · | $-41M | $-35M | $-42M | · | $-16M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $79M | $96M | $77M | $88M | $119M | $65M | $98M | $243M | $161M | $144M | $138M | $214M | $183M | $188M | $176M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Prepaid Expense | $9M | $7M | $9M | $7M | $6M | $8M | $8M | $4M | $4M | $7M | $12M | $8M | $13M | $12M | $14M | $12M | |
| Current Assets | $229M | $263M | $311M | $336M | $386M | $434M | $462M | $487M | $506M | $549M | $590M | $603M | $621M | $632M | $661M | $682M | |
| PP&E (Net) | $249.0K | $353.0K | $457.0K | $561.0K | $665.0K | $769.0K | $873.0K | $977.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $1M | · | · | · | $689.0K | · | · | · | $273.0K | · | |
| Other Non-current Assets | $3M | $3M | $3M | $5M | $4M | $4M | $197.0K | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | · | |
| Total Assets | $232M | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | |
| Accounts Payable | $10M | $9M | $13M | $4M | $9M | $7M | $4M | $6M | $5M | $21M | $4M | $395.0K | $4M | $700.0K | $3M | $1M | |
| Current Liabilities | $28M | $33M | $40M | $20M | $20M | $22M | $19M | $25M | $27M | $41M | $32M | $19M | $16M | $12M | $18M | $16M | |
| Capital Leases | · | · | $0 | $213.0K | $425.0K | $634.0K | $842.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Total Liabilities | · | · | $40M | $27M | $27M | $29M | $26M | $32M | $34M | $49M | $40M | $26M | $24M | $20M | $26M | $23M | |
| Common Stock | $80.0K | $80.0K | $78.0K | $78.0K | $81.0K | $85.0K | $84.0K | $84.0K | $84.0K | $84.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | $83.0K | |
| Paid-in Capital | $805M | $802M | $798M | $793M | $800M | $809M | $803M | $788M | $776M | $763M | $751M | $739M | $726M | $714M | $701M | $689M | |
| Retained Earnings | $-601M | $-568M | $-523M | $-478M | $-436M | $-398M | $-364M | $-331M | $-300M | $-259M | $-196M | $-157M | $-124M | $-95M | $-60M | $-25M | |
| AOCI | $-96.0K | $-97.0K | $174.0K | $238.0K | $37.0K | $118.0K | $233.0K | $641.0K | $-280.0K | $-181.0K | $207.0K | $-262.0K | $-310.0K | $-307.0K | $-684.0K | $-855.0K | |
| Stockholders' Equity | $204M | $234M | $275M | $316M | $364M | $411M | $439M | $459M | $476M | $504M | $555M | $582M | $602M | $618M | $641M | $663M | |
| Liabilities + Equity | $232M | $267M | $315M | $343M | $392M | $440M | $465M | $491M | $510M | $553M | $595M | $608M | $626M | $638M | $667M | $687M | |
| Shares Outstanding | 80,204,699 | 80,027,099 | 78,126,796 | 78,126,796 | 81,137,478 | 85,579,475 | 84,463,059 | 84,463,059 | 84,422,000 | 84,223,100 | 83,435,513 | 83,435,513 | 83,399,377 | 83,399,377 | 83,287,639 | 83,287,639 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $104.0K | $106.0K | |
| Stock-based Comp | $3M | $4M | $5M | $5M | $5M | $7M | $14M | $12M | $13M | $13M | $12M | $12M | $12M | $13M | $12M | $12M | |
| Operating Cash Flow | $-37M | $-46M | $-28M | $-40M | $-33M | $-31M | $-30M | $-23M | $-42M | $-40M | $-22M | $-18M | $-16M | $-30M | $-22M | $-21M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $20.0K | |
| Investing Cash Flow | $34M | $30M | $47M | $41M | $15M | $86M | $-3M | $-122M | $125M | $57M | $28M | $-59M | $47M | $24M | $33M | $-487M | |
| Stock Repurchased | · | · | $0 | $11M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $257.0K | $0 | $-11M | $-14M | $-347.0K | $0 | $117.0K | $0 | $150.0K | $0 | $92.0K | $0 | $165.0K | $0 | $147.0K | |
| Net Change in Cash | $-3M | $-16M | $18M | $-10M | $-32M | $55M | $-34M | $-145M | $82M | $17M | $6M | $-76M | $30M | $-5M | $12M | $-508M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.6% | -12.8% | · | -10.1% | -8.2% | -6.9% | · | -5.7% | -7.1% | -10.6% | · | -5.1% | -4.3% | -5.2% | · | -1.1% | |
| ROE | -11.6% | -14.1% | · | -10.9% | -8.8% | -7.5% | · | -6.0% | -7.5% | -11.2% | · | -5.3% | -4.5% | -5.5% | · | -1.3% | |
| ROIC | -17.2% | -20.6% | · | -14.5% | -11.4% | -9.6% | · | -8.2% | -9.9% | -13.9% | · | -7.1% | -5.9% | -6.8% | · | -1.7% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 7.9 | · | 16.7 | 19.2 | 19.9 | · | 19.3 | 19.0 | 13.3 | · | 31.9 | 38.4 | 51.2 | · | 43.6 | |
| Quick Ratio | 2.7 | 2.4 | · | 3.8 | 4.4 | 5.5 | · | 3.9 | 9.1 | 3.9 | · | 7.3 | 13.2 | 14.8 | · | 11.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.55 | $2.92 | · | $4.04 | $4.49 | $4.80 | · | $5.43 | $5.64 | $5.99 | · | $6.97 | $7.22 | $7.41 | · | $7.96 | |
| Cash Flow / Share | · | $-0.59 | · | · | · | $-0.36 | · | · | · | $-0.48 | · | · | · | $-0.36 | · | · | |
| Cash / Share | $0.95 | $0.99 | · | $0.99 | $1.08 | $1.40 | · | $1.17 | $2.88 | $1.91 | · | $1.65 | $2.56 | $2.20 | · | $2.12 | |
| EPS (TTM) | $-2.08 | $-2.11 | · | $-1.77 | $-1.61 | $-1.65 | · | $-2.06 | $-2.09 | $-1.95 | · | $-1.57 | $-1.27 | $-1.31 | · | $0.36 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $351M | $351M | · | $351M | $351M | $351M | · | $351M | $351M | $351M | · | $351M | $351M | $351M | · | $351M | |
| Net Income TTM | $-165M | $-170M | · | $-147M | $-136M | $-139M | · | $-174M | $-176M | $-164M | · | $-131M | $-106M | $-109M | · | $36M | |
| Market Cap | $373M | $431M | · | $227M | $292M | $256M | · | $283M | $279M | $340M | · | $250M | $312M | $279M | · | $474M | |
| P/E | -2.2 | -2.5 | · | -1.6 | -2.2 | -1.8 | · | -1.6 | -1.6 | -2.1 | · | -1.9 | -2.9 | -2.6 | · | 15.8 | |
| P/S | 1.1 | 1.2 | · | 0.6 | 0.8 | 0.7 | · | 0.8 | 0.8 | 1.0 | · | 0.7 | 0.9 | 0.8 | · | 1.3 | |
| P/B | 1.8 | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | |
| P / Tangible Book | 1.8 | 1.8 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | |
| P / Cash Flow | · | -9.3 | · | · | · | -8.4 | · | · | · | -8.5 | · | · | · | -9.4 | · | · | |
| Earnings Yield | -44.7% | -39.2% | · | -61.0% | -44.7% | -55.2% | · | -61.5% | -63.1% | -48.3% | · | -52.3% | -34.0% | -39.1% | · | 6.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | · | · | · | $351M |
| Betriebsgewinnmarge % | · | · | · | · | 39.4% |
| Nettoergebnis | $-158M | $-168M | $-136M | $-116M | $121M |
| Verwässerte EPS | $-1.94 | $-2.00 | $-1.63 | $-1.39 | $1.37 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.8 | 24.9 | 18.2 | 35.8 | 13.6 |
| Quick Ratio | 2.4 | 3.5 | 4.4 | 10.2 | 13.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | $-123M | $-87M |
Institutionelle Eigentümer (13F) 131 Einreicher · $285.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
131
Gehaltener Wert
$285.6M
Neue Positionen
19
Geschlossene Positionen
20
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 19 (-10 vs. Vorquartal) | 20 (+12 vs. Vorquartal) | 45 (+7 vs. Vorquartal) | 39 (+1 vs. Vorquartal) | -619K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $55.818.898 | 12.004.064 | 19,54% | Aktien |
| BlackRock, Inc. | $40.548.360 | 8.720.077 | 14,20% | Aktien |
| BML Capital Management, LLC | $32.328.335 | 6.952.330 | 11,32% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $22.388.355 | 4.814.700 | 7,84% | Aktien |
| VANGUARD GROUP INC | $15.090.783 | 4.227.110 | 5,28% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.786.608 | 2.964.862 | 4,83% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $9.651.721 | 2.075.639 | 3,38% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $9.108.898 | 1.958.435 | 3,19% | Aktien |
| STATE STREET CORP | $7.683.655 | 1.652.399 | 2,69% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.006.141 | 1.506.697 | 2,45% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $6.042.497 | 1.299.515 | 2,12% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $5.260.080 | 1.131.200 | 1,84% | Aktien |
| Rosalind Advisors, Inc. | $4.978.058 | 1.070.550 | 1,74% | Aktien |
| JPMORGAN CHASE & CO | $4.360.682 | 945.918 | 1,53% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.783.129 | 1.059.700 | 1,32% | Aktien |
| NORTHERN TRUST CORP | $3.511.862 | 755.239 | 1,23% | Aktien |
| MORGAN STANLEY | $3.345.743 | 719.514 | 1,17% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.930.360 | 630.185 | 1,03% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.839.323 | 610.607 | 0,99% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.468.480 | 530.856 | 0,86% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.184.575 | 469.801 | 0,76% | Aktien |
| CM Management, LLC | $1.650.750 | 355.000 | 0,58% | Aktien |
| BARCLAYS PLC | $1.621.239 | 348.653 | 0,57% | Aktien |
| D. E. Shaw & Co., Inc. | $1.605.115 | 345.186 | 0,56% | Aktien |
| BANQUE PICTET & CIE SA | $1.604.608 | 345.077 | 0,56% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.416.441 | 304.611 | 0,50% | Aktien |
| Nuveen, LLC | $1.321.916 | 284.283 | 0,46% | Aktien |
| Invesco Ltd. | $1.242.132 | 267.125 | 0,43% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.151.852 | 247.710 | 0,40% | Aktien |
| Quantinno Capital Management LP | $1.126.704 | 242.302 | 0,39% | Aktien |
| Opaleye Management Inc. | $1.092.750 | 235.000 | 0,38% | Aktien |
| HSBC HOLDINGS PLC | $1.023.272 | 221.009 | 0,36% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $979.020 | 210.542 | 0,34% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $961.551 | 206.785 | 0,34% | Aktien |
| Bank of New York Mellon Corp | $880.952 | 189.452 | 0,31% | Aktien |
| Auour Investments LLC | $823.050 | 177.000 | 0,29% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $793.555 | 170.657 | 0,28% | Aktien |
| CITADEL ADVISORS LLC | $731.092 | 157.224 | 0,26% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $668.304 | 124.220 | 0,23% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $608.685 | 130.900 | 0,21% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $552.220 | 118.757 | 0,19% | Aktien |
| STRS OHIO | $547.305 | 117.700 | 0,19% | Aktien |
| Jump Financial, LLC | $476.258 | 102.421 | 0,17% | Aktien |
| UBS Group AG | $439.457 | 94.507 | 0,15% | Aktien |
| RHUMBLINE ADVISERS | $423.720 | 91.124 | 0,15% | Aktien |
| Aldebaran Capital, LLC | $410.037 | 88.180 | 0,14% | Aktien |
| BANK OF AMERICA CORP /DE/ | $380.044 | 81.730 | 0,13% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $366.053 | 78.721 | 0,13% | Aktien |
| DEUTSCHE BANK AG\ | $327.360 | 70.400 | 0,11% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $326.000 | 70.000 | 0,11% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Radoff Family Foundation, Radoff Bradley Louis, JEC II Associates, LLC, The MOS Trust, MOS PTC, LLC, Torok Michael, Berman Howard H., Nerium Partners LP, Nerium Capital LLC, Flynn James P. ×3 Einreichungen | 17. April 2025 | 4,00% | Änderung | Vorstandskampagne | SEC |
| BML Investment Partners, L.P., Leonard Braden Michael | 16. Dezember 2024 | 8,50% | Erste Einreichung | Passive Anlage | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC ×2 Einreichungen | 28. November 2023 | · | Erste Einreichung | · | SEC |
| Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP ×3 Einreichungen | 24. September 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 17 Insider · 6 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jean-Pierre Sommadossi | President, CEO, and Chairman | 3. Februar 2026 M | 767.830 | 0 | 0 | $0 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal and Secretary | 11. März 2026 M | 823.576 | 0 | 0 | $0 |
| Janet Mj Hammond | Chief Development Officer | 31. Januar 2026 A | 127.665 | 0 | 0 | $0 |
| John Vavricka | Chief Commercial Officer | 31. Januar 2026 A | 82.594 | 0 | 0 | $0 |
| Maria Arantxa Horga | Chief Medical Officer | 31. Januar 2026 A | 96.086 | 0 | 0 | $0 |
| Wayne Foster | EVP, Chief Accounting Officer | 31. Januar 2026 A | 79.329 | 0 | 0 | $0 |
| Berman Howard H. | Direktor | 18. Juni 2026 A | · | 0 | 0 | $0 |
| Jerome M. Adams | Direktor | 18. Juni 2026 A | 92.350 | 0 | 0 | $0 |
| Bruno Lucidi | Direktor | 18. Juni 2026 A | 142.350 | 0 | 0 | $0 |
| Polly A. Murphy | Direktor | 18. Juni 2026 A | 121.745 | 2 | 0 | $50.874 |
| Bruce Polsky | Direktor | 18. Juni 2026 A | 124.806 | 0 | 0 | $0 |
| Barbara Gayle Duncan | Direktor | 18. Juni 2026 A | 92.350 | 0 | 0 | $0 |
| Arthur S Kirsch | Direktor | 18. Juni 2026 A | · | 0 | 0 | $0 |
| Franklin M Berger | Direktor | 18. Juni 2026 A | 536.097 | 0 | 0 | $0 |
| Andrew A. F. Hack | Direktor | 3. November 2020 C | 5.615.659 | 0 | 0 | $0 |
| Isaac Cheng | Direktor | 29. Oktober 2020 A | · | 0 | 0 | $0 |
| Chung K. Chu | · | 3. November 2020 C | 1.176.862 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 23 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,26% | 128.804 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,09% | 239.656 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 5.772 SH | 1. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 487.025 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 61.782 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.801.869 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 33.880 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 54.576 SH | 29. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 408.133 SH | 19. August 2026 | Täglich |
| PKW · Invesco Exchange-Traded Fund Trust | 0,01% | 31.682 SH | 1. Oktober 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 263.930 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 8.300 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 181.666 SH | 11. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 16.361 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 58.155 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 18.737 SH | 3. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 9.202 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 864.902 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.032.268 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.932 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 20 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 154.338 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 665.401 SH | 11. September 2026 | Täglich |
AVIR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 9 Analysten
KAUF
Median-Ziel
$10.00
+94,9%
3 33,3%
Starker Kauf
4 44,4%
Kauf
2 22,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-10-03Mittelwert-Ziel $9.42 +83,6%
← Unter allen Zielen
Aktueller Preis $5.13
Tief$7.00
Mittelwert$9.42
Hoch$11.25
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AVIR | $279M | -1.8 | · | · | -49.5% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| CTNM | · | -5.3 | · | · | -27.7% | · |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
| RLMD | $354M | -3.3 | 93.7% | · | -112.0% | · |
| TTRX | $116M | -32.8 | · | · | -141.7% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 12, 2026